Analysis of RHOA involvement in leukemia and lymphomas from published literature and open source databases shows alteration of RHOA in 1.7% cases mainly by inactivating mutations or deletions while RHOB, RHOC and effector molecules ROCK1 and ROCK2 are not altered (42, 43). Here, RHOA is linked to leukemia.